BSE

Cipla gets USFDA nod for generic HIV drug

New Delhi, June 20, 2018: Drug major Cipla on Tuesday said it has received approval from the US health regulator to market Efavirenz…

6 years ago

Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Ointment, 0 1 pc

Mumbai, April 21, 2018: Pharma Major.Glenmark Pharmaceuticals on Wednesday said that Glenmark Pharmaceuticals Inc USA has received final approval from…

7 years ago

Panacea Biotec Ltd receives EIR from USFDA for Oncology plant at Malpur, Baddi

Mumbai, March 15, 2018: Pharma Major, Panacea Biotec Ltd. has announced the receipt of Establishment Inspection Report (EIR) from the…

7 years ago

Sun Pharma’s travails with US regulator may drag on

Mumbai, March 08, 2018: Sun Pharmaceutical’s troubles with the US drug regulator will continue, as details of the recent observations…

7 years ago

Jubilant Life Sciences Ltd updates on cancellation of distillery license

Mumbai, March 07, 2018: Jubilant Life Sciences said that The Commissioner of State Excise, Maharashtra has passed an order dated March…

7 years ago

USFDA finishes pre-endorsement investigation at Biocon Malyasia

Mumbai, February 24, 2018: Pharma Noteworthy, Biocon said that USFDA has finished a pre-endorsement investigation of its assembling office in Malaysia…

7 years ago

USFDA finishes review of Natco Pharma MEKAGUDA Programming interface Facility with Zero perception

Mumbai, February 20,2018: Pharma Major, Natco phrama said that Assembled States Sustenance and Medication Organization (USFDA) has effectively finished administrative…

7 years ago

Natco Pharma Q3 net benefit up 12% at Rs 217.4 cr

New Delhi, February 08, 2018: The organization had posted a benefit after assessment of Rs 194.9 crore for the comparing…

7 years ago

Sun Pharma settles patent Litigation for generic Linzess

Mumbai, January 18, 2018: Pharma Major, Sun Pharmaceutical Industries announced that its wholly owned subsidiaries have reached an agreement with…

7 years ago